Zhi Yang, CEO of Fasikl, Presents on AI Therapeutics at the National Academy of Engineering Regional Meeting at Medtronic

(MINNEAPOLIS, Minn.) May 21, 2025 – Zhi Yang, CEO of Fasikl, presented at the National Academy of Engineering Regional Meeting at Medtronic Mounds View. The event explored recent advances and future directions in Transforming Healthcare at the Intersection of AI and Medical Devices.

Zhi highlighted Fasikl’s leadership in AI therapeutics, showcasing how AI enables personalized, adaptive stimulation therapies in medical devices. He shared results from a recent double-blind, randomized, multi-regional clinical trial, where Fasikl’s AI-based therapy significantly outperformed placebo.

He also introduced Fasikl’s proprietary microchip technologies and NeuroAI algorithms, which power the company’s flagship product, Felix. Looking ahead, Zhi announced the upcoming launch of a new generation of AI-driven medical devices – offering enhanced efficacy, safety, and scalability – and emphasized that AI therapeutics may redefine the future of healthcare by improving outcomes while reducing costs.